✦ LIBER ✦

Preliminary results of educate, a multicenter, community-based, open-label study of the effect of etanercept on skin and joint disease in patients with psoriatic arthritis

Book ID: 116580488
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 53 KB
Volume: 52
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2004.10.776

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of infliximab in

The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

✍ Gottlieb, Alice B.; Kalb, Robert E.; Blauvelt, Andrew; Heffernan, Michael P.; So 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 430 KB

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial

✍ Daniel J. Lovell; Edward H. Giannini; Andreas Reiff; Olcay Y. Jones; Rayfel Schn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Five-year results of the Multicenter Ran

Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients

✍ Jan-Malte Sinning; Dietrich Baumgart; Nikos Werner; Volker Klauss; Frank M. Baer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Effect of the CYP3A inhibitor ketoconazo

Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study

✍ Karthik Venkatakrishnan; Michael Rader; Ramesh K. Ramanathan; Suresh Ramalingam; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 163 KB

The Effect of Darapladib on Plasma Lipop

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

✍ Emile R. Mohler III; Christie M. Ballantyne; Michael H. Davidson; Markolf Hanefe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 265 KB